» Authors » Patrick S Ramsey

Patrick S Ramsey

Explore the profile of Patrick S Ramsey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 783
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Munoz J, Counts R, Lacue A, Ireland K, Ramsey P, Brandi K
Medicina (Kaunas) . 2025 Jan; 61(1). PMID: 39859095
Management of second-trimester placenta accreta spectrum (PAS) is currently center-dependent with minimal evidence-based practices. This study aims to analyze outcomes of hysterectomy as second-trimester active management (AM) versus cesarean hysterectomy...
2.
Chupp D, Rivera C, Zhou Y, Xu Y, Ramsey P, Xu Z, et al.
Nat Immunol . 2024 Jun; 25(8):1489-1506. PMID: 38918608
Humanized mice are limited in terms of modeling human immunity, particularly with regards to antibody responses. Here we constructed a humanized (THX) mouse by grafting non-γ-irradiated, genetically myeloablated Kit mutant...
3.
Zarudskaya O, Boyd A, Byrne J, Berkus M, Ramsey P
J Ultrasound Med . 2024 Jun; 43(9):1579-1593. PMID: 38888042
Our systematic review highlights that multiparametric PAI score assessment is a consistent tool with high sensitivity and specificity for prenatal prediction for placenta accreta spectrum (PAS) in high-risk population with...
4.
Mulhall J, Ireland K, Byrne J, Ramsey P, McCann G, Munoz J
Medicina (Kaunas) . 2024 Apr; 60(4). PMID: 38674323
: Placenta accreta spectrum (PAS) disorders are placental conditions associated with significant maternal morbidity and mortality. While antenatal vaginal bleeding in the setting of PAS is common, the implications of...
5.
Munter B, Boyd A, Tchani R, Gray J, Ramsey P
Am J Obstet Gynecol MFM . 2024 Apr; 6(6):101377. PMID: 38621440
Objective: Hepatic infarction is a rare complication of pregnancy most often associated with hemolysis, elevated liver enzymes, and low platelets syndrome. The objective of this review is to identify risk...
6.
Sanchez-Ramos L, Levine L, Sciscione A, Mozurkewich E, Ramsey P, Adair C, et al.
Am J Obstet Gynecol . 2024 Mar; 230(3S):S669-S695. PMID: 38462252
This review assessed the efficacy and safety of pharmacologic agents (prostaglandins, oxytocin, mifepristone, hyaluronidase, and nitric oxide donors) and mechanical methods (single- and double-balloon catheters, laminaria, membrane stripping, and amniotomy)...
7.
Munoz J, Einerson B, Silver R, Mulampurath S, Sherman L, Rameshwar P, et al.
AJOG Glob Rep . 2024 Mar; 4(1):100319. PMID: 38440154
Background: Placenta accreta spectrum disorders are a complex range of placental pathologies that are associated with significant maternal morbidity and mortality. A diagnosis of placenta accreta spectrum relies on ultrasonographic...
8.
Cheng C, Byrne J, Hernandez B, Michalek J, Kerns J, Ramsey P, et al.
Am J Obstet Gynecol MFM . 2024 Feb; 6(4):101314. PMID: 38373499
No abstract available.
9.
Munoz J, Ramsey P, Greebon L, Salazar E, McCann G, Byrne J
Eur J Obstet Gynecol Reprod Biol . 2023 Dec; 293:32-35. PMID: 38100939
Background: Placenta Accreta Spectrum (PAS) represents a particularly morbid condition for which blood transfusion is the leading cause. Delivery by cesarean hysterectomy is recommended for the management of PAS. Massive...
10.
Fitzgerald G, Newton J, Atasi L, Buniak C, Burgos-Luna J, Burnett B, et al.
Am J Obstet Gynecol MFM . 2023 Nov; 6(1):101229. PMID: 37984691
The incidence of placenta accreta spectrum, the deeply adherent placenta with associated increased risk of maternal morbidity and mortality, has seen a significant rise in recent years. Therefore, there has...